Frontlight ResearchEarly access
Trial site
Institutul Oncologic Prof. Dr. Ion Chiricuta
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Acute myeloid leukaemia1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Amgen1 trial
- Karyopharm Therapeutics Inc1 trial
- OSE Immunotherapeutics1 trial
- Quetzal Therapeutics1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Lung cancer1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026